These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 6496369
1. Propafenone: noninvasive evaluation of efficacy. Podrid PJ, Cytryn R, Lown B. Am J Cardiol; 1984 Nov 14; 54(9):53D-59D. PubMed ID: 6496369 [Abstract] [Full Text] [Related]
2. Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure. Brodsky MA, Allen BJ, Abate D, Henry WL. Am Heart J; 1985 Oct 14; 110(4):794-9. PubMed ID: 4050651 [Abstract] [Full Text] [Related]
3. Propafenone: a new agent for ventricular arrhythmia. Podrid PJ, Lown B. J Am Coll Cardiol; 1984 Jul 14; 4(1):117-25. PubMed ID: 6376591 [Abstract] [Full Text] [Related]
7. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. Coumel P, Leclercq JF, Assayag P. Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770 [Abstract] [Full Text] [Related]
8. Aggravation of electrically provoked ventricular tachycardia during treatment with propafenone. Stavens CS, McGovern B, Garan H, Ruskin JN. Am Heart J; 1985 Jul 14; 110(1 Pt 1):24-9. PubMed ID: 4013986 [Abstract] [Full Text] [Related]
9. Propafenone in the treatment of patients with malignant ventricular tachyarrhythmias. Kowey PR, Stohler JL, Friehling TD, Marinchak RA. Can J Cardiol; 1991 May 14; 7(4):175-80. PubMed ID: 2070286 [Abstract] [Full Text] [Related]
10. Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment. Naccarella F, Bracchetti D, Palmieri M, Marchesini B, Ambrosioni E. Am J Cardiol; 1984 Nov 01; 54(8):1008-14. PubMed ID: 6496321 [Abstract] [Full Text] [Related]
11. [Therapy of ventricular tachyarrhythmias refractory to lidocaine with propafenone (author's transl)]. Laimer H, Glogar D, Zilcher H. Acta Med Austriaca; 1981 Nov 01; 8(5):140-4. PubMed ID: 7331741 [Abstract] [Full Text] [Related]
12. [Treatment of recurrent ventricular tachycardias using oral propafenone]. Cointe R, Lévy S, Metge M, Vrancea F, Labrunie P, Valeix B, Gérard R. Arch Mal Coeur Vaiss; 1985 Oct 01; 78 Spec No():59-62. PubMed ID: 3938260 [Abstract] [Full Text] [Related]
14. Antiarrhythmic and electrophysiologic effects of oral propafenone. Prystowsky EN, Heger JJ, Chilson DA, Miles WM, Hubbard J, Zipes DP. Am J Cardiol; 1984 Nov 14; 54(9):26D-28D. PubMed ID: 6496366 [Abstract] [Full Text] [Related]
15. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia. Chilson DA, Heger JJ, Zipes DP, Browne KF, Prystowsky EN. J Am Coll Cardiol; 1985 Jun 14; 5(6):1407-13. PubMed ID: 3889099 [Abstract] [Full Text] [Related]
16. Acute and long-term efficacy of oral propafenone in patients with ventricular tachyarrhythmias. Budde T, Borggrefe M, Podczeck A, Martinez-Rubio A, Breithardt G. J Cardiovasc Pharmacol; 1991 Aug 14; 18(2):254-60. PubMed ID: 1717787 [Abstract] [Full Text] [Related]
17. Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias. Hohnloser SH, Raeder EA, Podrid PJ, Graboys TB, Lown B. Am Heart J; 1987 Jul 14; 114(1 Pt 1):1-7. PubMed ID: 3604854 [Abstract] [Full Text] [Related]
19. Antiarrhythmic efficacy and hemodynamic effects of cibenzoline in patients with nonsustained ventricular tachycardia and left ventricular dysfunction. Seals AA, Haider R, Leon C, Francis M, Young JB, Roberts R, Pratt CM. Circulation; 1987 Apr 14; 75(4):800-8. PubMed ID: 3549044 [Abstract] [Full Text] [Related]
20. Acute and long-term efficacy of propafenone in patients with sustained ventricular tachyarrhythmias: assessment with programmed ventricular stimulation. Podczeck A, Frohner K, Hief C, Stix G, Steinbach KK. Eur Heart J; 1991 Jul 14; 12(7):796-9. PubMed ID: 1889445 [Abstract] [Full Text] [Related] Page: [Next] [New Search]